AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
99 hedge funds and large institutions have $865M invested in Aegerion Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
21% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 33
28% less call options, than puts
Call options by funds: $14.2M | Put options by funds: $19.7M
Holders
99
Holding in Top 10
3
Calls
$14.2M
Puts
$19.7M
Top Buyers
| 1 | +$42.9M | |
| 2 | +$22.3M | |
| 3 | +$17.3M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$9.97M |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
+$6.94M |
Top Sellers
| 1 | -$38.8M | |
| 2 | -$15.7M | |
| 3 | -$12.6M | |
| 4 |
Goldman Sachs
New York
|
-$11.8M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$11.3M |